Pharma
Scripps researchers have designed a bacterium with two unnatural bases, called X and Y, which could someday help them produce new molecules for medical therapies
Research led by scientists at the University of Birmingham shows more precisely how G protein-coupled receptors, which are the key target of a large number of drugs, work
Articles in the December 2017 special issue of SLAS Discovery present a snapshot of innovation in the MALDI application space as it stands today
These new compounds are some of the only new class of antibiotics to join the market recently as human therapeutics
Invitrogen TrueCut Cas9 Protein v2 is a next generation CRISPR-Cas9 protein designed to deliver maximum editing efficiency in a broad range of cells
New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific's portfolio of genome editing products
Selective C-H functionalization holds particular promise for the pharmaceutical industry
The technique is expected to find application not just in the pharmaceutical chemistry industry but also in a wide range of other chemical industries
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs
Technique may predict which therapies a patient is most sensitive or resistant to
